Effect of low-dose dual blockade of renin–angiotensin system on urinary TGF-β in type 2 diabetic patients with advanced kidney disease-Reference-Cited by-同舟云学术

Effect of low-dose dual blockade of renin–angiotensin system on urinary TGF-β in type 2 diabetic patients with advanced kidney disease

Published:2005-12-05 Issue:3 Volume:21 Page:683-689
ISSN:1460-2385
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:

Author:

Song Joon Ho,Cha Seok Ho,Lee Hun Jae,Lee Seoung Woo,Park Geun Ho,Lee Seung Won,Kim Moon-Jae

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/21/3/683/6900976/gfi310.pdf

Reference20 articles.

1. Parving H-H, Østerby R, Ritz E. Diabetic nephropathy. In: Brenner BM, Levine S, (eds). The Kidney. 6th edn, Philadelphia, WB Saunders, 2000; 1731–1773

2. Taal MW, Brenner BM. Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists. Kidney Int2000; 57: 1803–1817

3. Wolf G, Ritz E. Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: Pathophysiology and indications. Kidney Int2005; 67: 799–812

4. Jacobsen P, Rossing K, Parving HH. Single versus dual blockade of the renin-angiotensin system (angiotensin-converting enzyme inhibitors and/or angiotensin II receptor blockers) in diabetic nephropathy. Curr Opin Nephrol Hypertens2004; 13: 319–324

5. Russo D, Minutolo R, Pisani A et al. Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy. Am J Kidney Dis2001; 38: 18–25

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of dual renin–angiotensin system (RAS) blockade for non-elderly diabetic kidney disease patients with preserved eGFR;International Urology and Nephrology;2024-07-17

2. Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease;Cochrane Database of Systematic Reviews;2024-04-29

3. Combination Therapy Use and Associated Events in Clinical Practice Following Dissemination of Trial Findings: A De-Implementation Study Using Interrupted Time Series Analysis;Clinical Therapeutics;2024-01

4. Angiotensin‐converting enzyme inhibitor induced cough compared with placebo, and other antihypertensives: A systematic review, and network meta‐analysis;The Journal of Clinical Hypertension;2023-07-07

5. Efficacy and safety of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers in diabetic nephropathy: a systematic review and meta-analysis;Annals of Palliative Medicine;2022-03